De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.

The mechanism controlling the exit from herpes simplex virus latency (HSV) is of central importance to recurrent disease and transmission of infection, yet interactions between host and viral functions that govern this process remain unclear. The cascade of HSV gene transcription is initiated by the...

Full description

Bibliographic Details
Main Authors: Richard L Thompson, Chris M Preston, Nancy M Sawtell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-03-01
Series:PLoS Pathogens
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19325890/?tool=EBI
id doaj-d7ce86a1337b4473817dfc18a398f8be
record_format Article
spelling doaj-d7ce86a1337b4473817dfc18a398f8be2021-04-21T17:07:20ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742009-03-0153e100035210.1371/journal.ppat.1000352De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.Richard L ThompsonChris M PrestonNancy M SawtellThe mechanism controlling the exit from herpes simplex virus latency (HSV) is of central importance to recurrent disease and transmission of infection, yet interactions between host and viral functions that govern this process remain unclear. The cascade of HSV gene transcription is initiated by the multifunctional virion protein VP16, which is expressed late in the viral replication cycle. Currently, it is widely accepted that VP16 transactivating function is not involved in the exit from latency. Utilizing the mouse ocular model of HSV pathogenesis together with genetically engineered viral mutants and assays to quantify latency and the exit from latency at the single neuron level, we show that in vivo (i) the VP16 promoter confers distinct regulation critical for viral replication in the trigeminal ganglion (TG) during the acute phase of infection and (ii) the transactivation function of VP16 (VP16TF) is uniquely required for the exit from latency. TG neurons latently infected with the VP16TF mutant in1814 do not express detectable viral proteins following stress, whereas viruses with mutations in the other major viral transcription regulators ICP0 and ICP4 do exit the latent state. Analysis of a VP16 promoter/reporter mutant in the background of in1814 demonstrates that the VP16 promoter is activated in latently infected neurons following stress in the absence of other viral proteins. These findings support the novel hypothesis that de novo expression of VP16 regulates entry into the lytic program in neurons at all phases of the viral life cycle. HSV reactivation from latency conforms to a model in which stochastic derepression of the VP16 promoter and expression of VP16 initiates entry into the lytic cycle.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19325890/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Richard L Thompson
Chris M Preston
Nancy M Sawtell
spellingShingle Richard L Thompson
Chris M Preston
Nancy M Sawtell
De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.
PLoS Pathogens
author_facet Richard L Thompson
Chris M Preston
Nancy M Sawtell
author_sort Richard L Thompson
title De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.
title_short De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.
title_full De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.
title_fullStr De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.
title_full_unstemmed De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.
title_sort de novo synthesis of vp16 coordinates the exit from hsv latency in vivo.
publisher Public Library of Science (PLoS)
series PLoS Pathogens
issn 1553-7366
1553-7374
publishDate 2009-03-01
description The mechanism controlling the exit from herpes simplex virus latency (HSV) is of central importance to recurrent disease and transmission of infection, yet interactions between host and viral functions that govern this process remain unclear. The cascade of HSV gene transcription is initiated by the multifunctional virion protein VP16, which is expressed late in the viral replication cycle. Currently, it is widely accepted that VP16 transactivating function is not involved in the exit from latency. Utilizing the mouse ocular model of HSV pathogenesis together with genetically engineered viral mutants and assays to quantify latency and the exit from latency at the single neuron level, we show that in vivo (i) the VP16 promoter confers distinct regulation critical for viral replication in the trigeminal ganglion (TG) during the acute phase of infection and (ii) the transactivation function of VP16 (VP16TF) is uniquely required for the exit from latency. TG neurons latently infected with the VP16TF mutant in1814 do not express detectable viral proteins following stress, whereas viruses with mutations in the other major viral transcription regulators ICP0 and ICP4 do exit the latent state. Analysis of a VP16 promoter/reporter mutant in the background of in1814 demonstrates that the VP16 promoter is activated in latently infected neurons following stress in the absence of other viral proteins. These findings support the novel hypothesis that de novo expression of VP16 regulates entry into the lytic program in neurons at all phases of the viral life cycle. HSV reactivation from latency conforms to a model in which stochastic derepression of the VP16 promoter and expression of VP16 initiates entry into the lytic cycle.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19325890/?tool=EBI
work_keys_str_mv AT richardlthompson denovosynthesisofvp16coordinatestheexitfromhsvlatencyinvivo
AT chrismpreston denovosynthesisofvp16coordinatestheexitfromhsvlatencyinvivo
AT nancymsawtell denovosynthesisofvp16coordinatestheexitfromhsvlatencyinvivo
_version_ 1714666668385370112